Xiaojun Liu
Hebei Medical University(CN)Second Hospital of Hebei Medical University(CN)
Publications by Year
Research Areas
CAR-T cell therapy research, Cancer-related molecular mechanisms research, MicroRNA in disease regulation, RNA modifications and cancer, RNA Research and Splicing
Most-Cited Works
- → Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition(2016)917 cited
- → MicroRNA Expression Signature and Antisense-Mediated Depletion Reveal an Essential Role of MicroRNA in Vascular Neointimal Lesion Formation(2007)913 cited
- → Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells(2018)838 cited
- → T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans(2013)583 cited
- → Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice(2015)556 cited
- → A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors(2016)505 cited